(Q35585366)

9 August 2017

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients (English)

1 reference

9 August 2017

0 references

0 references

1 reference

Anne H Cross

1

0 references

author name string

Jennifer L Stark

2

1 reference

9 August 2017

Joanne Lauber

3

1 reference

9 August 2017

Michael J Ramsbottom

4

1 reference

9 August 2017

Jeri-Anne Lyons

5

1 reference

9 August 2017

language of work or name

1 reference

14 August 2006

1 reference

Journal of Neuroimmunology

9 August 2017

1 reference

9 August 2017

180

1 reference

9 August 2017

1-2

1 reference

9 August 2017

63-70

1 reference

Role of C5a in inflammatory responses

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Complement activation determines the therapeutic activity of rituximab in vivo.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

B cells and antibodies in CNS demyelinating disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Intrathecal activation of the complement system and disability in multiple sclerosis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

A study of oligoclonal band negative multiple sclerosis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

An open label study of the effects of rituximab in neuromyelitis optica

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Treatment of IgM antibody associated polyneuropathies using rituximab

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Maintenance of serological memory by polyclonal activation of human memory B cells.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

The expression of potency of neutralizing antibodies for interferons and other cytokines

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Immunoglobulin G, A, and M--clonal restriction in multiple sclerosis cerebrospinal fluid and serum--analysis by two-dimensional electrophoresis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769354

Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbations and remissions

24 October 2018

1 reference

12 December 2020

Immunoglobulins promote remyelination in the central nervous system

1 reference

12 December 2020

Multiple sclerosis progression in a natural history study: predictive value of cerebrospinal fluid free kappa light chains

1 reference

12 December 2020

B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide

1 reference

12 December 2020

Oligoclonal band number as a marker for prognosis in multiple sclerosis

1 reference

12 December 2020

Intrathecal IgG synthesis: marker of progression in multiple sclerosis patients

1 reference

12 December 2020

Intrathecal IgM synthesis in neurologic diseases: Relationship with disability in MS

1 reference

12 December 2020

A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells

1 reference

12 December 2020

Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis

1 reference

12 December 2020

Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis

1 reference

12 December 2020

10.1016/J.JNEUROIM.2006.06.029

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference